Incremental cost-effectiveness analysis (Functional Limit scenario).

<p>ICER = Incremental cost-effectiveness ratio, colpo. = colposcopic biopsy</p><p>*For initial screen plus colposcopic biopsy when indicated. Excludes colposcopic biopsy for VIA because not clinically relevant.</p><p>**HPV DNA screening was dominated by Pap 2 in that it offered fewer cases for a higher total cost.</p><p>***Pap 1 was dominated by Pap 2 in that the marginal cost of identifying cases was higher than with Pap 2.</p><p>Incremental cost-effectiveness analysis (Functional Limit scenario).